Adverse Events Module

Adverse Events Module

For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.

Adverse Events Module path is as follows:

Study -> Results Section -> Adverse Events Module -> Event Groups

Study -> Results Section -> Adverse Events Module -> Serious Events

Study -> Results Section -> Adverse Events Module -> Other Events

Adverse Events Module


Ignite Creation Date: 2025-12-25 @ 2:08 AM
Ignite Modification Date: 2025-12-26 @ 12:34 AM
NCT ID: NCT04638660
Description: None
Frequency Threshold: 5
Time Frame: 15 days
Study: NCT04638660
Study Brief: Safety and Efficacy of Nyxol (0.75% Phentolamine Ophthalmic Solution) in Subjects With Dim Light Vision Disturbances
Event Groups(If Any):

Event Groups

Title Description Deaths # Affected Deaths # At Risk Serious # Affected Serious # At Risk Other # Affected Other # At Risk View
Phentolamine Ophthalmic Solution 0.75% One drop in both eyes at or near bedtime (8PM to 10PM) Phentolamine Ophthalmic Solution 0.75%: 0.75% phentolamine ophthalmic solution (Nyxol), a non-selective alpha-1 and alpha-2 adrenergic antagonist 0 None 0 71 23 71 View
Phentolamine Ophthalmic Solution Vehicle One drop in both eyes at or near bedtime (8PM to 10PM) Phentolamine Ophthalmic Solution Vehicle (Placebo): Topical sterile ophthalmic solution 0 None 0 73 2 73 View
Serious Events(If Any):
Other Events(If Any):

Other Events

Term Type Organ System Vocab View
Instillation site pain SYSTEMATIC_ASSESSMENT General disorders None View
Dysgeusia SYSTEMATIC_ASSESSMENT Nervous system disorders None View
Conjunctival Hyperaemia SYSTEMATIC_ASSESSMENT Eye disorders None View
Instillation site erythema SYSTEMATIC_ASSESSMENT General disorders None View